Phase 1 trial of a novel C'Dot drug conjugate (CDC), ELU001, in patients with solid tumors known to overexpress folate receptor alpha (FRα) Meeting Abstract

  

Authors:	Ma, W. W.; Tolcher, A. W.; Perez, C. A.; Orr, D.; Hamilton, E. P.; Zhao, Y.; Murciano-Goroff, Y. R.; Anders, C. K.; Adams, G. P.; Reddick, C. W.; Bayever, E.
Abstract Title:	Phase 1 trial of a novel C'Dot drug conjugate (CDC), ELU001, in patients with solid tumors known to overexpress folate receptor alpha (FRα)
Meeting Title:	2023 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	41
Issue:	16 Suppl.
Meeting Dates:	2023 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-06-01
Language:	English
DOI:	10.1200/JCO.2023.41.16_suppl.TPS3159
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164018187&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: TPS3159 -- Meeting was also available virtually -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/209651